Abbreviation footnote: HCS, holocarboxylase synthetase; SMVT, sodium dependent multivitamin transporter; PC, pyruvate carboxylase; MCD, multiple carboxylase deficiency; B-AMP, bio tinyl-5´-AMP; 8-Br-cGMP, 8-bromo-cyclic guanosine monophosphate.
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Introduction.
The vitamin biotin functions as the cofactor in carboxylation reactions where it acts as the carboxyl carrier. In human cells, there are five biotin dependent carboxylases: pyruvate carboxylase (PC), propionyl-CoA carboxylase (PCC), methylcrotonyl-CoA carboxylase and two forms of acetyl-CoA carboxylase (ACC-1 and ACC-2). Biotin-dependent carboxylases catalyze key reactions in gluconeogenesis, branched-chain amino acid catabolism and fatty acid synthesis, roles which underscore its broad impact in human metabolism (1) .
During evolution, mammals lost the ability to synthesize biotin and now satisfy their need for the vitamin through a delicate balance between dietary biotin and reutilization of endogenous, protein-bound biotin (1, 2) . To ensure a continuous supply of the vitamin, eukaryotic organisms have developed a biotin utilization cycle that depends on the participation of three different proteins. The first is a transporter for the uptake of biotin through the plasma membrane.
Although different biotin transporters have been proposed in different species, only one has been confirmed by cDNA cloning (3, 4) . The sodium dependent multivitamin transporter (SMVT) transports biotin, panthotenic acid and lipoic acid and is characterized by a seemingly high km for biotin (5, 6) . The second is holocarboxylase synthetase (HCS). It catalyzes the biotinylation of carboxylases in a two-step, ATP-dependent reaction in which biotin is first activated to biotinyl-5'-AMP (B-AMP) and then transferred to the apocarboxylase substrate (7) (8) (9) . The third enzyme of the biotin cycle is biotinidase. It is responsible for releasing biotin from protein-bound biotin by hydrolysis of biocytin (biotinyl-lysine) or short biotinylated peptides generated during digestion or turnover of endogenous carboxylases (10) .
In humans, the balance between the utilization of exogenous and recycled biotin can be disrupted by genetic abnormalities with devastating consequences for metabolic homeostasis.
Loss of HCS or biotinidase activity produces the neonatal or juvenile forms, respectively, of the 4 disease, multiple carboxylase deficiency (MCD) (1, 11, 12) . Both forms of MCD are potentially fatal. However, all clinical and biochemical manifestations can be reversed with pharmacological doses of biotin (1) .
Biotin has been implicated in a number of other cellular processes including DNA and RNA synthesis, nitric oxide-like activity on cGMP synthesis, cell growth and histone biotinylation (13) (14) (15) (16) (17) (18) (19) . The non-classical effect of biotin that has been best characterized is its role in gene expression. Several groups have shown that in laboratory animals and cell cultures, biotin is required for optimal expression and activity of glucokinase, phosphofructokinase, ornithine transcarbamylase, asyaloglycoprotein receptor, PCC, ACC-1 and HCS (20-28).
We investigated the effect of biotin-deficiency in human fibroblasts and HepG2 cells and observed a reduction in mRNA levels for HCS, PCC-alpha subunit and ACC-1, which are all returned to normal level after biotin supplementation (29) . Biotin achieves this outcome by triggering a signaling cascade involving soluble guanylate cyclase (sGC) and cGMP-dependent protein kinase (PKG). Significantly, cells from patients with neonatal MCD required 100 times more biotin than control cells to restore HCS mRNA to normal level following growth in biotindepleted medium (29) . These results suggested that the product of the HCS reaction, B-AMP, and not biotin per se is responsible for the effect of biotin on gene expression.
Although HCS-sGC-PKG-mediated signaling could explain the effect of biotin on gene expression, the physiological significance of this type of regulation and its relevance to the phenotype of MCD are unknown. The down regulation of HCS and carboxylases during biotin depletion seems self-destructive given the essential function of biotin. Since the biotin cycle presents independent mechanisms for the utilization of exogenous biotin (uptake via SMVT) versus cellular biotin (recycling via biotinidase), we have examined the regulation of SMVT and biotinidase mRNA expression as a function of biotin access to determine if the regulation is 5 aimed at control of the biotin cycle. We have also assessed the regulation of PC given its prominenc e at the junction of gluconeogenesis, glycolysis and the Krebs cycle. Significantly, we show that SMVT and PC mRNA expression, along with that of HCS, respond to biotin availability while biotinidase does not. We demonstrate, in biotin-replete versus biotin-deficient rats, that while the HCS-sGC-PKG pathway down-regulates biotin utilization in liver and kidney, it does not in brain. Instead, we show that the biotin cycle in the brain is constitutively expressed or even enhanced in its capacity to scavenge biotin during biotin depletion. We put forward the hypothesis that the differential effect of biotin in liver and brain may be part of an altruistic mechanism for the repression of biotin utilization in liver so as to ensure the continued supply of biotin to the brain when dietary biotin becomes limiting or deficient.
Experimental procedures.
Materials. Biotin and 8 -bromo-cyclic guanosine monophosphate (8-Br-cGMP) were from Sigma-Aldrich, St. Louis, MO. The human hepatoblastoma cell line, HepG2, was from the American Type Cell Collection and the rat C6 glioma line was kindly provided by Dr. H. Pasantes, Universidad Nacional Autónoma de México. Normal human fibroblasts, fibroblasts from a patient with MCD (MCD-MK) and rabbit antibody to HCS, raised against an N-terminal peptide of human HCS, residues 58-78, have been described previously (19) . Cell cultures were maintained in alpha-MEM medium containing high glucose (GIBCO/BRL; biotin concentration 0.40 ?M) supplemented with 10% heat-inactivated FBS, 100 units/ml penicillin, and 100 µg/ml streptomycin (biotin-replete medium). Biotin-deficient medium was prepared using biotin free MEM medium, dialyzed FBS (GIBCO/BRL) and the same antibiotic concentration. Male Wistar rats were provided by Instituto de Investigaciones Biomédicas, UNAM. Biotin-replete and biotin-deficient diets for laboratory animals were purchased from ICN Nutritional Biochemicals, Cleveland OH.
Cell culture experiments. The methods for biotin starvation of cell cultures are essentially as described previously (29) . Briefly, cells were grown in biotin-repl ete or biotin-deficient medium at 37°C with 5% CO2 for up to 15 days. The medium was changed at three day intervals. PCR products were evaluated following electrophoresis on agarose gels and were quantified by densitometry using a molecular imager FX (BIORAD, Hercules CA.) and normalized to ? -actin mRNA as previously described (29) . The ? -actin mRNA was present at equivalent levels in all RNA samples ( Animal model for biotin deficiency. Male Wistar rats, age 21-28 days, were placed in air filtered cages and fed a biotin-free diet ad libitum . The animals were sacrificed after [8] [9] [10] weeks when liver carboxylase activities were less than 30% of those of control animals fed a normal diet (28, 30) . The selected organs were rapidly removed, rinsed in PBS and frozen in liquid nitrogen. Total RNA was isolated from brain, liver and kidney from normal and biotin deficient rats and mRNA levels were determined as described above.
Biotin content in carboxylases from normal and biotin deficient rats. Liver and brain from rats fed on normal and biotin deficient diet as described above were harvested and washed on 
Results .
Biotin availability regulates mRNA levels of the biotin utilization cycle proteins in HepG2 cells.
To determine if key components of the biotin cycle are under the control of the exogenous biotin concentration, we examined mRNA levels of SMVT and biotinidase, two proteins which control entry of biotin into the cycle. We also assessed PC mRNA, because of its central role in metabolism, and compared all three with HCS, which we previously showed is regulated by 9 biotin availability (29) . Human HepG2 cells were plated in triplicate in three experimental groups: cells incubated in biotin-replete medium as control, cells incubated in biotin-deficient medium for 15 days, and cells incubated in a biotin-deficient medium for 15 days followed by the addition of 1 uM biotin for 24 h (biotin-recovery medium). After the treatments, total RNA was isolated and mRNA levels were determined by rtPCR (Fig. 1a) . Biotin starvation produced a significant decrease in the mRNA levels for SMVT (-71% ±2), HCS (-64% ±5) and PC (-68% ±3) compared to cells in biotin-replete medium. However, there was little change in the mRNA for biotinidase (-16% ±2) or actin, used as the control (Fig. 1b) . The reduction in mRNA levels proved to be specific for biotin deficiency because the addition of the vitamin to 15 day biotinstarved cultures restored the mRNA's for SMVT, HCS and PC to normal levels (Fig. 1b) .
Biotinidase mRNA remained essentially unchanged in cells incubated in biotin-deficient or recovery medium relative to the control medium.
We confirmed that the reduction in mRNA was reflected in the level of protein, using HCS for the analysis (Fig. 1c) . A Western bl ot of HCS from the HepG2 treatment cultures shows that the amo unt of HCS protein is reduced one -third for cells grown in biotin-deficient medium compared to the level obtained for cells in biotin-replete medium. As observed for the mRNA, the addition of biotin to the deficient cultures resulted in normalization of the protein to the level obtained for control cells (data not shown).
We previously showed that the biotin effects on HCS and PCC-alpha subunit mRNA are mediated by sGC and cGMP (29) . To determine if the expression of SMVT, PC and biotinidase are under similar control, we examined the effect of stimulating biotin-starved cells with 8-BrcGMP in place of biotin. The addition of 1 mM 8-Br-cGMP for 24 hours increased the mRNA of SMVT and PC, as well as HCS, to starting levels, mimicking the response to biotin (Fig. 1a and Table 1 ). In contrast, biotinidase mRNA, which was essentially unchanged in biotindepleted medium (to 84% ±2 of biotin-replete level), showed little change (to 91% ±4 and 112% ±10 of normal levels) on the addition of biotin or 8-Br-cGMP, respectively. These results show that biotin and the cGMP analogue have similar effects on mRNA levels in cells that had been previously depleted of biotin.
Biotin-cycle mRNA levels in MCD cells.
We had shown that fibroblasts from a patient with neonatal MCD require much higher levels of biotin to elicit a change in its HCS mRNA following incubation in biotin-deficient medium (29) .
In this experiment, we determined if there is also an effect on SMVT and bi otinidase mRNA and, consequently, if HCS is also implicated in their regulation. For MCD cells, we made use of the HCS-deficient MCD-MK cell line which is homozygous for R508W, a mutation that gives its HCS an elevated km for biotin (12,29,31). Normal and MCD-MK cells were incubated in biotin-deficient medium and compared for their ability to stimulate an increase in mRNA levels for SMVT, HCS and biotinidase in response to the addition of different concentrations of biotin.
When control and MCD-MK fibroblasts were grown in biotin-free medium, SMVT mRNA was decreased in each cell line as expected (12% ±2 of pretreatment levels) and a similar reduction was obtained for HCS mRNA (to 29% ±4) (Fig. 2a, b) . In contrast, the two cell lines differed markedly in their response to the re-addition of biotin. In normal cells, biotin addition for 24 hours resulted in a stimulation in the level of both mRNA species. For SMVT mRNA, the maximum recovery, to the level observed in biotin-replete cells, was observed at the lowest biotin concentration used, 0.001 uM, with higher concentrations giving marginally lower recoveries. Although biotinidase mRN A was not reduced by biotin deficiency, the addition of increasing biotin to the culture medium produced a tendency toward a reduction in biotinidase mRNA levels from 100% at 0.001 uM biotin to 78% ±2 at 0.1 uM biotin (Fig. 2a) . In keeping with our previo us study (29) , HCS mRNA also showed recovery to starting levels, but it increased more slowly with increasing biotin concentration so that full recovery was obtained at only the highest concentration of biotin (1 uM).
The MCD-MK cells behaved very differently (Fig. 2b) . At 0.001 uM biotin, SMVT mRNA increased from the biotin-starved level of 12% ±9 of the biotin-replete level to 50% ±5 and showed little additional change (63% ±7 at 1 uM biotin). Like normal cells, biotinidase mRNA was not reduced in biotin-depleted medium, although it did show a downward trend on the readdition of biotin at the higher biotin concentrations. As observed before (29) , HCS mRNA increased only at the higher biotin concentrations, beginning at 0.1 uM biotin and reaching 79% ±4 of starting level at 1 uM biotin. These results show that, like HCS, SMVT requires at least 100 times more biotin than normal cells to achieve a similar increase in its mRNA level, while Biotin cycle mRNA levels in rat tissues.
The above results suggest that low nutrient biotin or mutations in MCD result in a diminished capacity of cells to restore mRNA levels of proteins involved in the utilization of exogenous biotin while leaving unaffected the enzyme required for recycling endogenous vitamin. This mechanism of mRNA regulation would seem to work against maintaining metabolic homeostasis because a reduction in the expression of SMVT and HCS mRNA would be expected to diminish the capacity to scavenge biotin in a low biotin nutrient source. To assess the physiological role of such a seemingly self-destructive process, we made use of a rat model of biotin deficiency and examined the impact of biotin starvation in different tissues. Male Wistar rats were fed a biotin-free diet and, after eight weeks, they presented with a characteristic biotin deficiency phenotype and a dramatic decrease in biotin-dependent PC and PCC activities (30) . The mRNA levels of SMVT, HCS, PC and biotinidase were determined in different organs by densitometric analysis of rtPCR products. For clarity, only the results obtained in brain and liver are presented (Fig. 3) , since preliminary data for kidney gave similar expression patterns as for liver.
Biotin deficiency produced a decrease in liver mRNA levels (SMVT, 42% ±3 of the biotinreplete level; HCS, 55% ±3 ; PC, 17% ±2 ), while showing little change in brain (SMVT, 90% ±1 ; HCS, 94% ±7 ; PC, 96% ±3 ) in biotin-deficient rats (Fig. 3a-c) . Biotinidase mRNA was unaffected in liver (91% ±2 of biotin replete level), resembling the data obtained in human cell
cultures. Yet, in the brain of deficient rats, we found a modest increase (to 129% ±10) over the value observed in normal animals (Fig. 3d) . Biotin starvation had no effect on the mRNA levels of the reference gene actin (Fig. 3e) in either liver or brain. Western blot of liver and brain HCS showed that biotin starvation reduced the amount of HCS protein in the liver to half the level in control animals, but had no effect on the brain enzyme (Fig. 1c) .
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These results suggest that biotin regulates mRNA levels in liver and kidney (not shown), but not brain. To determine if this is a tissue-specific or cell-specific property, we determined if the resistance of brain to the effect of biotin-starvation would extend to rat C6 glioma cells.
Following incubation in biotin-free medium, mRNA levels were reduced significantly as observed for HepG2 cells, with SMVT at 20% ±10 of normal levels and PC at 33% ±6 (Fig.   4a,b) . Similarly, biotin starvation had no effect on biotinidase mRNA (96% ±4 ; Fig. 4c ). The addition of biotin to the deficient cultures raised the mRNA levels of SMVT and PC to 63% ±2 and 82% ±4 , respectively (Fig. 4a,b) while having no effect on biotinidase mRNA (Fig. 4c) .
These results indicate that rat C6 glioma cells behave like HepG2 cells rather than the brain of biotin-starved rats.
Biotin content in brain carboxylases is selectively maintained in biotin deficient rats.
These results suggest that the down-regulation of the biotin cycle in liver and constitutive expression in brain during periods of biotin deprivation are aimed at maximizing the assimilation of biotin into carboxylases in brain. In other tissues, through reduction in carboxylase protein and reduced biotin transfer (HCS deficiency), there should be very little protein-bound biotin. To assess the level of protein-bound biotin, we made use of steptavidin to probe Western blots of extracts of liver and brain of normal and biotin deficient rats. The results show that in biotin-deficient rats, the biotinylated forms of hepatic PC (128 kDa), PCC (74 kDa) and MCC (72 kDa) were reduced by 90% compared to control animals (Fig. 5) . In contrast in brain, there was no difference in the level of biotinylated carboxylases PC and MCC in normal versus biotin-deficient animals. As previously reported (32), PCC is much less abundant than MCC in liver and brain and under the present experimental conditions was not detectable in the brain from normal and deficient rats.
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Discussion.
We have investigated the regulation of the biotin cycle in cultured cells and rat liver under conditions of biotin starvation and replenishment. We have shown that SMVT and HCS, proteins critical to the utilization of exogenous or dietary biotin, respond to biotin deprivation by reduction in the steady state level of their mRNA's. In contrast, biotin re-utilization via biotinidase is unaffected by biotin status. Importantly, the biotin cycle appears to be constitutively expressed in brain, with biotinidase mRNA even modestly elevated in limiting biotin. We hypothesize that under conditions of reduced or limiting access to biotin, expression of mRNAs associated with biotin utilization in liver, but also kidney, become repressed, while remaining constitutively expressed in brain. We propose that this mechanism of regulation is aimed at sparing the essential function of biotin in brain at the expense of liver during biotin deprivation.
In this model, we suggest that the reduction in biotin utilization in liver during periods of reduced dietary availability maximizes access of the brain to circulating free biotin, both dietary and endogenously generated. The free bi otin is directed to brain because the reduction in SMVT, HCS and carboxylases mRNA's in liver reduces their capacity to utilize biotin, while leaving free biotin in circulation. Our finding that biotinidase mRNA is constitutively expressed in cells and peripheral tissues complements the findings of Baumgartner and colleagues who showed that biotin deficiency does not affect the enzymatic activity of biotinidase in cell cultures (33) . We suggest therefore that the release of protein-bound biotin continues in biotindepleted liver, but some of this biotin is also directed to the circulation due to the reduction in utilization. Significantly, the brain is an organ in which a high affinity biotin transporter has been documented (34) . One therefore can picture the flow of dietary and released endogenous biotin from liver to the circulation and transport to the brain where constitutive uptake and utilization via HCS, as well as increased endogenous reutilization via elevated biotinidase, assure maintenance of functional carboxylase activities in periods of biotin deprivation.
The sequestering of biotin to the brain was confirmed by the examination of the level of biotinylated carboxylases in the liver and brain of normal and biotin-deficient rats. Despite severe biotin-deficiency, the level of biotinylated carboxylases in brain was similar to that of control animals, while liver was grossly deficient in carboxylase-biotin content. Previous studies had also shown that brain biotin content as well as the activity of biotin-dependent carboxylases are relatively preserved in the face of biotin starvation and systemic biotin deficiency in rats (35) (36) (37) (38) (39) . The reduction in protein-bound biotin in liver was likely due to a combination of a decrease in carboxylase levels, due to reduced synt hesis, and the impair in biotin transfer, due to reduced synthesis of HCS. The latter is in keeping with the previous detection of accumulated unbiotinylated carboxylases (apocarboxylases) in the liver of biotin deficient rats (40, 41) . Thus, through the expedient of repression of mRNA synthesis, the reduction in biotinylated carboxylases in liver could be doubly assured through down-regulation in the synthesis of both apocarboxylases and HCS.
Mechanistically, the regulation of the biotin cycle appears to occur through an HCS-sGC-PKG pathway. We previously showed that the repression of HCS, ACC-1 and PCC-alpha subunit mRNA in limiting biotin can be reversed with cGMP (as 8-Br-cGMP) and that reactivation can be blocked with inhibitors of sGC or PKG (29) . We have extended these findings to PC and SMVT mRNAs which also respond to cGMP and to biotinidase mRNA which does not. Indeed, the constitutive expression of biotinidase may explain the extended period, in cell cultures or rats, required to produce biotin deficiency. It likely reflects the time required for depletion of endogenous biotin which, through biotinidase, continues to be released throughout the biotin depletion period. In principle, biotinidase may contribute to cell survival by becoming the primary source of free biotin in liver to fuel metabolism through the activation of carboxylases.
It is possible that the 30% baseline level of HCS, SMVT and carboxylases mRNA's remaining in biotin-depleted cells is not meant to represent a shut-down of biotin utilization but to limit it to subsistence level of activity.
Our results for HCS are similar to those of Rodriguez-Meléndez et al, who showed that HCS mRNA was reduced in liver of biotin deficient rats, but with minimal reduction in brain. Unlike us, they did not observe a reduction of PC mRNA but this may have reflected a difference in detection method used, since PC as well as PCC activity and protein mass were reduced in their study (30) .
Our studies suggests that the biotin sparing to the brain is organ-specific rather than cell-type defined because when brain derived cells, represented by the rat C6 glioma cells, were cultured in a biotin-free medium, the mRNA levels of SMVT and PC were reduced in a similar fashion as those of HepG2 cells and fibroblasts. This model is supported by previous studies that have also shown a strong reduction of carboxylase activities in neurons, oligodendroglia, and keratinocytes grown in biotin deficient medium (33) .
This hypothesis for sparing the brain at the expense of liver underscores the importance of functional carboxylase to brain metabolism (35) . In this organ, the activity of biotin-dependent PC is important for the regeneration of alpha-ketoglutarate due to the release of glutamate and GABA from neurons and glutamine export from glia (36, 37) . Recently, it was shown that the rate of neuronal and glial pyruvic carboxylation could operate at as much as 30% and 40-60% of the Krebs cycle turnover rate, respectively (37) . This may provide a rational for an orga nism to temporarily sacrifice the biotin requirement of other organs to assure the maintenance of efficient brain development and function.
Differential depletion of nutrients in liver versus brain is not unique to biotin. For many years it has been known that the pattern of traffic of glucose from one tissue to another is distinct in the well-fed versus starvation states in mammals. During starvation, most tissues, but not the brain, limit glucose consumption by internalizing GLUT4 transporters in response to a reduction in the insulin/glucagon ratio. Glucose influx into neurons is not dependent on insulin which assures the presence of this metabolite in the brain independently of the nutritional state of the organism. The rationale behind the tissue specific regulation of glucose utilization is that the brain depends almost entirely on it as an energy source. Thus a continuous supply of glucose to the brain is achieved by reducing its utilization by muscle tissue and maintaining the insulinindependent influx of glucose in neurons (42, 43) . The apparent importance of biotin-dependent carboxylases in brain metabolism suggests similarities between glucose and biotin sparing during nutritional deprivation. Biotinylation content of carboxylases was determined by densitometry as described in Experimental procedures. 
